Cite
HARVARD Citation
Turner, R. et al. (n.d.). Nilotinib effects on safety, tolerability, and biomarkers in Alzheimer's disease: A phase 2, double‐blind, randomized, placebo‐controlled trial. Alzheimer's & dementia. p. n/a. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Turner, R. et al. (n.d.). Nilotinib effects on safety, tolerability, and biomarkers in Alzheimer's disease: A phase 2, double‐blind, randomized, placebo‐controlled trial. Alzheimer's & dementia. p. n/a. [Online].